Animation - Understanding Immunotherapy for Lung Cancer

Slide Show - Understanding Immunotherapy for Lung Cancer

Animation - Immunotherapy Treatments for NSCLC

Slide Show - Immunotherapy Treatments for NSCLC

Animation - Immunotherapy Treatments for SCLC

Slide Show - Immunotherapy Treatments for SCLC

Expert Videos

1. What immunotherapy treatments are used for non-small cell lung cancer (NSCLC)?

2. What immunotherapy treatments are used for small cell lung cancer (SCLC)?

Expert Video - What immunotherapy treatments are used for small cell lung cancer (SCLC)?

Medical oncologist Dr. Manish Patel discusses how immunotherapy is used to treat small cell lung cancer (SCLC). Immunotherapy has been shown to improve outcomes in patients with both extensive-stage and limited-stage SCLC. In SCLC, immunotherapy has been used almost exclusively in combination with chemotherapy in patients with metastatic disease. He also discusses the immunotherapy drug called durvalumab, which is used after finishing chemotherapy and radiation therapy for earlier-stage SCLC. In addition, he provides an overview of the use of a new immunotherapy drug called tarlatamab, which is used in metastatic SCLC that has progressed despite chemotherapy and immunotherapy treatments.

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.

Section: Immunotherapy for Lung Cancer

Animation - Understanding Immunotherapy for Lung Cancer

Slide Show - Understanding Immunotherapy for Lung Cancer

Animation - Immunotherapy Treatments for NSCLC

Slide Show - Immunotherapy Treatments for NSCLC

Animation - Immunotherapy Treatments for SCLC

Slide Show - Immunotherapy Treatments for SCLC

Expert Videos

1. What immunotherapy treatments are used for non-small cell lung cancer (NSCLC)?

2. What immunotherapy treatments are used for small cell lung cancer (SCLC)?

Other Modules:

Treatment and Management of Lung Cancer

Targeted Therapy in Non-Small Cell Lung Cancer

Understanding Non-Small Cell Lung Cancer (NSCLC)

Understanding Small Cell Lung Cancer (SCLC)

Screening for Lung Cancer

Lung Cancer Screening for Black Americans

Lung Cancer Screening for Native Americans

Diagnosis and Screening of Lung Cancer

Staging of Lung Cancer

Understanding Biomarker Testing in Non-Small Cell Lung Cancer

NGS and CGP for Lung Cancer

Understanding Clinical Trials in Lung Cancer

Lung Cancer Clinical Trials and the US Black Community

Lung Cancer Clinical Trials and Native Americans

NSCLC Treatment When You Have an EGFR Mutation

NSCLC Treatment Options When You Have an EGFR Mutation

NSCLC Treatment When You Have a KRAS Mutation

NSCLC Treatment Options When You Have a KRAS Mutation

NSCLC Treatment for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET

Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers

Understanding Prehabilitation for Lung Cancer Surgery

Your Prehabilitation Plan for Lung Cancer Surgery

Patient & Caregiver Stories:

Mr. Satterfield's Story

Sharon’s Story

Terri's Story

Tricia's Story

This educational activity has been developed by A Breath of Hope Lung Foundation and Mechanisms in Medicine Inc.

This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Foundation Inc., Bristol-Myers Squibb Grants and Giving, Foundation Medicine, Genentech, Jazz Pharmaceuticals, Merck Sharp & Dohme LLC, Neogenomics, Novartis, Pfizer, and Takeda Oncology.

This website is part of the Animated Patient^® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed shared decisions, and partner with their healthcare professionals for optimal outcomes.